Table 2.
Summary of the roles of PSGL-1 in bacterial and viral infections.
| Type of infection | Example of pathogen | Reported process | Reference |
|---|---|---|---|
| Bacteria | Salmonella typhimurium | PSGL-1/P-selectin interactions lead to neutrophil recruitment and host defenses | (81) |
| Staphylococcus aureus | Staphylococcal superantigen-like 5 can bind sLex expressed on PSGL-1 by neutrophils. Therefore, neutrophils cannot be activated or recruited via PSGL-1/P-selectin binding | (82, 83) | |
| Streptococcus pneumoniae | PSGL-1 is involved in neutrophil phagocytosis through binding to the capsular polysaccharide and cell wall autolysin, LytA | (93) | |
| Viruses | SARS-CoV and SARS-CoV-2 | PSGL-1 impairs the incorporation of the viral spike (S) glycoproteins into pseudovirions. Thus, it blocks virus attachment and subsequent infection of target cells | (96) |
| Murine leukemia virus | PSGL-1 inactivates murine leukemia virus infectivity | (95) | |
| Influenza A virus | PSGL-1 disrupts the infectivity of this nonretroviral enveloped virus | (95) | |
| HIV | In the presence of PSGL-1, the produced HIV particles harbor a defective membrane (without gp120 and gp41). They are therefore ineffective at binding to target cells | (25, 95) | |
| PSGL-1 cytoplasmic domain (T393) binds F-actin and, therefore, restricts cellular actin dynamics. Without F-actin to recruit, HIV cannot complete the reverse transcription process. | (97) |